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For the last 30 years a consider-
able part of my work has centered 
round the problem of combining ir-
radiation and surgery in the treat-
ment of uterine cancer, both of 
cervix and corpus. There was noth-
ing unusual about the latter be-
cause radium in the uterus before 
operation, or in the vagina after 
operation, has been used by sur-
geons for many years. But as far as 
carcinoma of the cervix was con-
cerned the concept of operating on 
irradiated tissues was considered 
foolhardy to an extreme and was 
condemned by such outstanding au-
thorities at the time as the late 
Victor Bonney of London and 
Heyman of Radiumhemmet, Stock-
holm. The reasons for my determi-
nation to explore this field, and the 
philosophy that activated the re-
search, have been published else-
where (Stallworthy, 1964; 1966). 
Mr. Bonney, who was my chief in 
London in 1936-1937, when I was 
one of his last pupils, was inter-
ested in our Oxford research as 
was Joe Vincent Meigs [late Presi-
dent of the Society of Pelvic Sur-
geons]. Both were sceptical of its 
outcome and neither lived to see 
the results. I will use two recent 
cases to illustrate the following 
four points: 
1. That high doses of irradia-
tion, though not a desirable prelude 
to surgery, are not an absolute con-
traindication. 
2. That the final criterion of 
radiation response is not measured 
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by exfoliative cytology, but by the 
length of time the patient lives 
without further evidence of tu-
mour formation. 
3. That planned combined ther-
apy ab initio is less traumatic for 
both patient and surgeon than 
salvage surgery after failed irradia-
tion. 
4. That teamwork involving ra-
diotherapist and surgeon is essen-
tial for success. 
Two Case Histories 
The first illustrative case con-
cerns an adenocarcinoma of the 
cervix in an English woman aged 
34 and para 3. This was in July 
1963. She had a stage 2 carcinoma 
of the cervix, reasonably well dif-
ferentiated and graded Broder 2. 
She was referred to the radiother-
apy department at Liverpool, where 
a total dose of 9,000 mg hours of 
radium was given to the cervix and 
vaginal vault. This was followed by 
high energy irradiation with cobalt 
60 to a total dose of 5,520 rads. 
Two and a half years later bleed-
ing recurred, and examination con-
firmed the presence of invasive 
cancer. The position looked hope-
less because of the so-called recur-
rence after very high dose radia-
tion therapy. 
The patient was transferred to 
Oxford for a second opinion, and 
as the tumour was clinically op-
erable and the patient only 36 with 
three children dependent upon her, 
it was decided that she should be 
given the only opportunity of sur-
vival now open to her. On 3-3-66 
a Wertheim hysterectomy was per-
formed with full appreciation of 
the risks involved, particularly in 
relation to necrosis and fistulae. 
Examination of the surgical speci-
men demonstrated tumour cells in 
the cervix, corpus, paracolpos, para-
metrium, and left obturator node. 
Fortunately the postoperative pro-
gress was uneventful, and the pa-
tient nine months later is alive, 
well, and caring for her family. 
The second patient came from 
America. She was aged 60, nulli-
parous, and in November, 1964, 
had been treated in New York for 
an adenocarcinoma of the cervix, 
stage 3, and poorly differentiated. 
A total dose of 5,300 mg hours 
of radium application was given to 
the cervix with associated high en-
ergy irradiation using cobalt 60 
and a dose of 4,000 rads. She was 
carefully followed up and on 10-1-
65, just one year after treatment, 
she was symptom-free but was ad-
mitted to hospital for a progress 
study. The report was given: "Ex-
cellent response to radiotherapy." 
The patient was an English-
woman who had lived for some 
years in New York where her hus-
band had recently died, and she de-
cided to return to Britain. Within 
five months after the progress 
study, there was a recurrence of 
uterine pain and vaginal bleeding. 
Active growth was demonstrated at 
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curettage. Further irradiation was 
considered useless and the prog-
nosis looked grim. Her surgeon in 
New York had given her a letter 
of introduction to the Oxford De-
partment, where on 4-18-66 a 
Wertheim hysterectomy was per-
formed, 19 months after the irradi-
ation. Growth was demonstrated in 
the cervix and in the parametrium, 
but not in the corpus or the nodes. 
Postoperative recovery was un-
eventful, and two months later the 
patient, when reporting for her 
follow-up examination, stated "I 
feel human once again." 
Discussion 
The total series of post-irradia-
tion Wertheims now performed at 
Oxford since 1942 is 360, and the 
fact that there have been only two 
deaths and two ureteric fistulae has 
clearly established that this is a safe 
and practical procedure. In spite of 
the increasing number of patients 
similar to the two illustrated, who 
are now referred for salvage, there 
has not been a ureteric fistula for 
many years. Two modifications of 
the original Bonney technique, de-
signed to protect the ureter and 
bladder, have been described else-
where (Stallworthy, 1964) and 
have proved effective. One death 
was due to pulmonary embolism 
and the other to Asian influenza 
with a fulminating septicaemia 
which killed the patient within a 
few hours the day before she was 
due to go home. 
The ideal in combined therapy is 
for each case to be assessed by 
both the radiotherapist and the 
surgeon and for the treatment to 
be planned from the beginning. 
This has resulted in a 71 % five-
year apparent cure rate in 188 pa-
tients operated upon after irradia-
tion between 1950 and October 
1961. Moreover, in the last three 
years of _this study, nine of 15 
patients with malignant nodes were 
alive and well five years later, a 
survival rate of 60% . 
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It may well be, as suggested by 
Powers ( 1964), that smaller doses 
of preoperative irradiation would 
prove effective. We have used doses 
considered to be lethal by the ra-
diotherapists, but proven not to be 
in a high percentage of patients. 
Dr. Powers has summarised the ex-
perimental evidence to support the 
concept of preoperative irradiation, 
and our considerable clinical mate-
rial confirms his view. Recently Sir 
Eric Riches ( 1965) has advocated 
the same combination of therapy 
in the treatment of malignant renal 
tumours, and the available evi-
dence, both experimental and clini-
cal, indicates that the concept of 
preoperative irradiation, which has 
proved effective in the treatment of 
tumours in the genito-urinary tract, 
could be applied to the treatment 
of cancer elsewhere. 
We have much to learn before it 
can be claimed with truth that the 
treatment of cervical cancer has 
been perfected, but great progress 
has been made. Combined therapy, 
carefully planned for each patient 
when technically possible, has elimi-
nated irradiation failures with so-
called recurrent uterine cancer. It 
avoids the necessity of salvage op-
erations after high dose irradiation 
and greatly improves the results of 
radical surgery. 
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